ClinicalTrials.Veeva

Menu

Mindfulness Interventions to Improve Health Activation, Coping, and Stress Among Childhood Cancer Survivors

St. Jude Children's Research Hospital logo

St. Jude Children's Research Hospital

Status

Active, not recruiting

Conditions

Lymphoma
Childhood Cancer
Leukemia

Treatments

Device: Headspace

Study type

Interventional

Funder types

Other

Identifiers

NCT06053268
MINDHACS
NCI-2023-09351 (Other Identifier)

Details and patient eligibility

About

This study will explore feasibility and acceptability of using a daily mobile mindfulness app to cope with stress. In addition, feasibility of digital health data collection procedures including wrist-worn devices and ecological momentary assessments will be examined.

PRIMARY OBJECTIVES

  • Determine the feasibility and acceptability of completing the 30-day mobile mindfulness program
  • Evaluate the feasibility of digital health data collection procedures to detect autonomic nervous system (ANS) activation associated with stress (e.g., electrodermal activity, pulse rate variability, skin temperature) via wearable devices and self-reported ecological momentary assessments (EMA) among adult survivors of childhood cancer in the SJLIFE cohort
  • Generate preliminary data to estimate the effect size and power needed for an extramurally funded randomized controlled trials (RCT) examining the impact of daily mindfulness mediation on biomarkers of ANS activation, coping, health behaviors, and cardiometabolic outcomes in a cohort of survivors of childhood cancer.

Full description

Prior to engaging in the intervention participants will complete baseline assessments of stress and coping. Participants will then engage in a daily mindfulness practice via the Headspace mobile application. The basic application program includes daily 10-minute sessions in guided mindfulness meditation that include mindful breathing, body awareness, emotion and thought recognition, and attentional control. During the first and fourth week of the intervention, participants will complete EMAs assessing mood, current activity, and intervention engagement. Participants will also wear a wrist-worn device to assess biomarkers of stress. At the completion of the intervention participants will complete follow-up assessments related to intervention and data collection procedures feasibility and acceptability as well as coping behaviors and stress.

Enrollment

50 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Research participant is at least 18 years old at enrollment
  • Research participant is followed by St. Jude Children's Research Hospital (SJCRH)
  • Research participant has a diagnosis history of leukemia or lymphoma
  • Research participant takes part in the St. Jude Lifetime Cohort Study (SJLIFE)
  • Research participant has elevated psychological stress scores of 6 or greater on most recent SJLIFE questionnaire
  • Participant can speak and read English

Exclusion criteria

  • Research participant currently engages in mindful stress-reduction practices >2x per week (e.g., tai chi, meditation)
  • Research participant takes psychiatric medications or medications that impact cardiac functioning, beta-blockers, alpha-blockers
  • Research participant wears a pacemaker
  • Research participant has a diagnosis of a congenital heart disease
  • Research participant has no access to a smartphone
  • Research participant has elevated pain interference scores (T≥70)

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

50 participants in 1 patient group

Single-arm, within-subject pilot: EmbracePlus smartwatch
Experimental group
Description:
Prior to engaging in the intervention participants will complete baseline assessments of stress and coping. Participants will then engage in a daily mindfulness practice via the Headspace mobile application. The basic application program includes daily 10-minute sessions in guided mindfulness meditation that include mindful breathing, body awareness, emotion and thought recognition, and attentional control. During the first and fourth week of the intervention, participants will complete EMAs assessing mood, current activity, and intervention engagement. Participants will also wear a wrist-worn device to assess biomarkers of stress. At the completion of the intervention participants will complete follow-up assessments related to intervention and data collection procedures feasibility and acceptability as well as coping behaviors and stress.
Treatment:
Device: Headspace

Trial contacts and locations

1

Loading...

Central trial contact

Rachel Webster, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems